Chaccour, CarlosRabinovich, Regina2017-05-102017-05-102017-04-241475-2875https://hdl.handle.net/2445/110769The development of ivermectin as a complementary vector control tool will require good quality evidence. This paper reviews the different eco-epidemiological contexts in which mass drug administration with ivermectin could be useful. Potential scenarios and pharmacological strategies are compared in order to help guide trial design. The rationale for a particular timing of an ivermectin-based tool and some potentially useful outcome measures are suggested.13 p.application/pdfengcc by (c) Chaccour et al., 2017http://creativecommons.org/licenses/by/3.0/es/MalàriaAssaigs clínicsMalariaClinical trialsinfo:eu-repo/semantics/article2017-05-03info:eu-repo/semantics/openAccess28434405